GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sichuan Biokin Pharmaceutical Co Ltd (SHSE:688506) » Definitions » Revenue per Share

Sichuan Biokin Pharmaceutical Co (SHSE:688506) Revenue per Share : ¥14.59 (TTM As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Sichuan Biokin Pharmaceutical Co Revenue per Share?

Sichuan Biokin Pharmaceutical Co's revenue per share for the three months ended in Sep. 2024 was ¥0.27. Sichuan Biokin Pharmaceutical Co's revenue per share for the trailing twelve months (TTM) ended in Sep. 2024 was ¥14.59.

Warning Sign:

Sichuan Biokin Pharmaceutical Co Ltd revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue Per Share Growth Rate of Sichuan Biokin Pharmaceutical Co was 836.30% per year. During the past 3 years, the average Revenue Per Share Growth Rate was -21.80% per year. During the past 5 years, the average Revenue Per Share Growth Rate was -14.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Sichuan Biokin Pharmaceutical Co's Revenue per Share or its related term are showing as below:

SHSE:688506' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -21.8   Med: -10.3   Max: -6.1
Current: -21.8

During the past 10 years, Sichuan Biokin Pharmaceutical Co's highest 3-Year average Revenue Per Share Growth Rate was -6.10% per year. The lowest was -21.80% per year. And the median was -10.30% per year.

SHSE:688506's 3-Year Revenue Growth Rate is ranked worse than
90.56% of 911 companies
in the Drug Manufacturers industry
Industry Median: 6.4 vs SHSE:688506: -21.80

Sichuan Biokin Pharmaceutical Co Revenue per Share Historical Data

The historical data trend for Sichuan Biokin Pharmaceutical Co's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sichuan Biokin Pharmaceutical Co Revenue per Share Chart

Sichuan Biokin Pharmaceutical Co Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.12 2.94 2.23 1.94 1.40

Sichuan Biokin Pharmaceutical Co Quarterly Data
Dec13 Dec14 Jun15 Dec18 Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 0.47 13.62 0.23 0.27

Competitive Comparison of Sichuan Biokin Pharmaceutical Co's Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Sichuan Biokin Pharmaceutical Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sichuan Biokin Pharmaceutical Co's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sichuan Biokin Pharmaceutical Co's PS Ratio distribution charts can be found below:

* The bar in red indicates where Sichuan Biokin Pharmaceutical Co's PS Ratio falls into.



Sichuan Biokin Pharmaceutical Co Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Sichuan Biokin Pharmaceutical Co's Revenue Per Share for the fiscal year that ended in Dec. 2023 is calculated as

Revenue Per Share (A: Dec. 2023 )=Revenue (A: Dec. 2023 )/Shares Outstanding (Diluted Average) (A: Dec. 2023 )
=561.871/400.256
=1.40

Sichuan Biokin Pharmaceutical Co's Revenue Per Share for the quarter that ended in Sep. 2024 is calculated as

Revenue Per Share (Q: Sep. 2024 )=Revenue (Q: Sep. 2024 )/Shares Outstanding (Diluted Average) (Q: Sep. 2024 )
=109.833/400.995
=0.27

Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥14.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sichuan Biokin Pharmaceutical Co  (SHSE:688506) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Sichuan Biokin Pharmaceutical Co Revenue per Share Related Terms

Thank you for viewing the detailed overview of Sichuan Biokin Pharmaceutical Co's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Sichuan Biokin Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 161, Baili Road, No. 1, Building 1, Cross-strait Science and Technology Industrial Park, Wenjiang District, Sichuan Province, Chengdu, CHN, 611130
Sichuan Biokin Pharmaceutical Co Ltd is a chemical drug and biological drug-based company that integrates drug research and development, production and marketing.
Executives
Zhu Yi Directors, senior managers

Sichuan Biokin Pharmaceutical Co Headlines

No Headlines